The 2022 IPO market is already revving up with 3 stock listings from Boston-area biotechs

[unable to retrieve full-text content]The first Friday of the new year will see market debuts from Vigil Neuroscience (VIGL), CinCor Pharma (CINC), and Amylyx Pharmaceuticals (AMLX).